|
|
Previous Article | Table of Contents | Next Article 
Fas antigen expression on CD34+ human marrow cells is induced by interferon
gamma and tumor necrosis factor alpha and potentiates cytokine-mediated
hematopoietic suppression in vitro
J Maciejewski, C Selleri, S Anderson and NS Young
Hematology Branch, National Heart, Lung, and Blood Institute, National
Institutes of Health, Bethesda, MD 20892, USA.
Activation of Fas antigen, a cell surface receptor molecule, by its ligand
results in transduction of a signal for cell death. The Fas system has been
implicated in target cell recognition, clonal development of immune
effector cells, and termination of the cellular immune response. Fas
antigen expression on lymphocytes is regulated by interferon gamma (IFN
gamma) and tumor necrosis factor alpha (TNF alpha), cytokines that also
have inhibitory effects on hematopoiesis. We investigated Fas antigen
expression on human marrow cells and the effects of Fas activation on
hematopoiesis in vitro. Freshly isolated immature hematopoietic cells, as
defined by the CD34 marker, did not express Fas antigen at levels
detectable by fluorescent staining. CD34+ cells, which include progenitors
and stem cells, showed low levels of Fas expression in culture, even in the
presence of growth factors. Stimulation by TNF alpha and IFN gamma markedly
increased Fas antigen expression on CD34+ cells. Anti-Fas antibody, which
mimics the action of the putative ligand, enhanced IFN gamma- and TNF
alpha-mediated suppression of colony formation by bone marrow (BM) in a
dose-dependent manner. This effect did not require the presence of
accessory cells. Colony formation from mature (CD34+ CD38+) and immature
(CD34+ CD38-) progenitor cells and long-term culture initiating cells were
susceptible to the inhibitory action of anti-Fas antibody in the presence
of IFN gamma and TNF alpha. Apoptosis assays performed on total BM cells
and CD34+ cells showed that anti-Fas antibody induced programmed cell death
of CD34+ BM cells.(ABSTRACT TRUNCATED AT 250 WORDS)
Volume 85,
Issue 11,
pp. 3183-3190,
06/01/1995
Copyright © 1995 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. O. Iversen, K. B. Andersson, A. V. Finsen, I. Sjaastad, T. G. von Lueder, O. M. Sejersted, H. Attramadal, and G. Christensen
Separate mechanisms cause anemia in ischemic vs. nonischemic murine heart failure
Am J Physiol Regulatory Integrative Comp Physiol,
March 1, 2010;
298(3):
R808 - R814.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Tang, M. J. Desierto, J. Chen, and N. S. Young
The role of the Th1 transcription factor T-bet in a mouse model of immune-mediated bone-marrow failure
Blood,
January 21, 2010;
115(3):
541 - 548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Dufour, E. Ferretti, F. Bagnasco, O. Burlando, M. Lanciotti, U. Ramenghi, P. Saracco, M. T. Van Lint, D. Longoni, G. F. Torelli, et al.
Changes in cytokine profile pre- and post-immunosuppression in acquired aplastic anemia
Haematologica,
December 1, 2009;
94(12):
1743 - 1747.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. O. Omokaro, M. J. Desierto, M. A. Eckhaus, F. M. Ellison, J. Chen, and N. S. Young
Lymphocytes with Aberrant Expression of Fas or Fas Ligand Attenuate Immune Bone Marrow Failure in a Mouse Model
J. Immunol.,
March 15, 2009;
182(6):
3414 - 3422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Niu, S. Strahotin, B. Hewes, B. Zhang, Y. Zhang, D. Archer, T. Spencer, D. Dillehay, B. Kwon, L. Chen, et al.
Cytokine-Mediated Disruption of Lymphocyte Trafficking, Hemopoiesis, and Induction of Lymphopenia, Anemia, and Thrombocytopenia in Anti-CD137-Treated Mice
J. Immunol.,
April 1, 2007;
178(7):
4194 - 4213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Sloand, L. Pfannes, G. Chen, S. Shah, E. E. Solomou, J. Barrett, and N. S. Young
CD34 cells from patients with trisomy 8 myelodysplastic syndrome (MDS) express early apoptotic markers but avoid programmed cell death by up-regulation of antiapoptotic proteins
Blood,
March 15, 2007;
109(6):
2399 - 2405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. S. Young, R. T. Calado, and P. Scheinberg
Current concepts in the pathophysiology and treatment of aplastic anemia
Blood,
October 15, 2006;
108(8):
2509 - 2519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Schiller, J. Slack, J. D. Hainsworth, J. Mason, M. Saleh, D. Rizzieri, D. Douer, and A. F. List
Phase II Multicenter Study of Arsenic Trioxide in Patients With Myelodysplastic Syndromes
J. Clin. Oncol.,
June 1, 2006;
24(16):
2456 - 2464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Vey, A. Bosly, A. Guerci, W. Feremans, H. Dombret, F. Dreyfus, D. Bowen, A. Burnett, M. Dennis, V. Ribrag, et al.
Arsenic Trioxide in Patients With Myelodysplastic Syndromes: A Phase II Multicenter Study
J. Clin. Oncol.,
June 1, 2006;
24(16):
2465 - 2471.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Boula, M. Voulgarelis, S. Giannouli, G. Katrinakis, M. Psyllaki, C. Pontikoglou, F. Markidou, G. D. Eliopoulos, and H. A. Papadaki
Effect of cA2 Anti-Tumor Necrosis Factor-{alpha} Antibody Therapy on Hematopoiesis of Patients with Myelodysplastic Syndromes.
Clin. Cancer Res.,
May 15, 2006;
12(10):
3099 - 3108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Mirandola, G. Gobbi, C. Ponti, I. Sponzilli, L. Cocco, and M. Vitale
PKC{epsilon} controls protection against TRAIL in erythroid progenitors
Blood,
January 15, 2006;
107(2):
508 - 513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Felli, F. Pedini, A. Zeuner, E. Petrucci, U. Testa, C. Conticello, M. Biffoni, A. Di Cataldo, J. A. Winkles, C. Peschle, et al.
Multiple Members of the TNF Superfamily Contribute to IFN-{gamma}-Mediated Inhibition of Erythropoiesis
J. Immunol.,
August 1, 2005;
175(3):
1464 - 1472.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Sloand, L. Mainwaring, M. Fuhrer, S. Ramkissoon, A. M. Risitano, K. Keyvanafar, J. Lu, A. Basu, A. J. Barrett, and N. S. Young
Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome
Blood,
August 1, 2005;
106(3):
841 - 851.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Risitano
New Challenges to Developing Animal Models for Human Immune-Mediated Marrow Failure
Clin. Med. Res.,
May 1, 2005;
3(2):
63 - 64.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chen
Animal Models for Acquired Bone Marrow Failure Syndromes
Clin. Med. Res.,
May 1, 2005;
3(2):
102 - 108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Askenasy, E. S. Yolcu, I. Yaniv, and H. Shirwan
Induction of tolerance using Fas ligand: a double-edged immunomodulator
Blood,
February 15, 2005;
105(4):
1396 - 1404.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Yang, I. Dybedal, D. Bryder, L. Nilsson, E. Sitnicka, Y. Sasaki, and S. E. W. Jacobsen
IFN-{gamma} Negatively Modulates Self-Renewal of Repopulating Human Hemopoietic Stem Cells
J. Immunol.,
January 15, 2005;
174(2):
752 - 757.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Gutierrez, F. Lindeboom, A. Langeveld, F. Grosveld, S. Philipsen, and D. Whyatt
Homotypic signalling regulates Gata1 activity in the erythroblastic island
Development,
July 1, 2004;
131(13):
3183 - 3193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tsantes, S. Tassiopoulos, S. I. Papadhimitriou, S. Bonovas, L. Kavalierou, G. Vaiopoulos, and I. Meletis
Suboptimal Erythropoietic Response to Hypoxemia in Idiopathic Pulmonary Fibrosis
Chest,
August 1, 2003;
124(2):
548 - 553.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Dybedal, L. Yang, D. Bryder, I. Aastrand-Grundstrom, K. Leandersson, and S. E. W. Jacobsen
Human reconstituting hematopoietic stem cells up-regulate Fas expression upon active cell cycling but remain resistant to Fas-induced suppression
Blood,
July 1, 2003;
102(1):
118 - 126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. A. Papadaki, A. G. Eliopoulos, T. Kosteas, C. Gemetzi, A. Damianaki, H. Koutala, J. Bux, and G. D. Eliopoulos
Impaired granulocytopoiesis in patients with chronic idiopathic neutropenia is associated with increased apoptosis of bone marrow myeloid progenitor cells
Blood,
April 1, 2003;
101(7):
2591 - 2600.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I.-J. Chung, C. Dai, and S. B. Krantz
Stem cell factor increases the expression of FLIP that inhibits IFNgamma -induced apoptosis in human erythroid progenitor cells
Blood,
February 15, 2003;
101(4):
1324 - 1328.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Mufti, A. F. List, S. D. Gore, and A. Y.L. Ho
Myelodysplastic Syndrome
Hematology,
January 1, 2003;
2003(1):
176 - 199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kitaura, N. Nagata, Y. Fujimura, H. Hotokezaka, N. Yoshida, and K. Nakayama
Effect of IL-12 on TNF-{alpha}-Mediated Osteoclast Formation in Bone Marrow Cells: Apoptosis Mediated by Fas/Fas Ligand Interaction
J. Immunol.,
November 1, 2002;
169(9):
4732 - 4738.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. F. List
New Approaches to the Treatment of Myelodysplasia
Oncologist,
April 1, 2002;
7(90001):
39 - 49.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Silvestris, P. Cafforio, M. Tucci, and F. Dammacco
Negative regulation of erythroblast maturation by Fas-L+/TRAIL+ highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma
Blood,
February 15, 2002;
99(4):
1305 - 1313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Coulter, A. Doseff, P. Sweeney, Y. Wang, C. B. Marsh, M. D. Wewers, and D. L. Knoell
Opposing Effect by Cytokines on Fas-Mediated Apoptosis in A549 Lung Epithelial Cells
Am. J. Respir. Cell Mol. Biol.,
January 1, 2002;
26(1):
58 - 66.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. O. Iversen, P. R. Woldbaek, T. Tonnessen, and G. Christensen
Decreased hematopoiesis in bone marrow of mice with congestive heart failure
Am J Physiol Regulatory Integrative Comp Physiol,
January 1, 2002;
282(1):
R166 - R172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bovolenta, E. Pilotti, M. Mauri, M. Turci, P. Ciancianaini, P. Fisicaro, U. Bertazzoni, G. Poli, and C. Casoli
Human T-cell leukemia virus type 2 induces survival and proliferation of CD34+ TF-1 cells through activation of STAT1 and STAT5 by secretion of interferon-gamma and granulocyte macrophage-colony-stimulating factor
Blood,
January 1, 2002;
99(1):
224 - 231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. de Thonel, A. Bettaieb, C. Jean, G. Laurent, and A. Quillet-Mary
Role of protein kinase C zeta isoform in Fas resistance of immature myeloid KG1a leukemic cells
Blood,
December 15, 2001;
98(13):
3770 - 3777.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Bryder, V. Ramsfjell, I. Dybedal, K. Theilgaard-Monch, C.-M. Hogerkorp, J. Adolfsson, O. J. Borge, and S. E. W. Jacobsen
Self-Renewal of Multipotent Long-Term Repopulating Hematopoietic Stem Cells Is Negatively Regulated by FAS and Tumor Necrosis Factor Receptor Activation
J. Exp. Med.,
October 1, 2001;
194(7):
941 - 952.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Dybedal, D. Bryder, A. Fossum, L. S. Rusten, and S. E. W. Jacobsen
Tumor necrosis factor (TNF)-mediated activation of the p55 TNF receptor negatively regulates maintenance of cycling reconstituting human hematopoietic stem cells
Blood,
September 15, 2001;
98(6):
1782 - 1791.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Matsushima, M. Nakashima, K. Oshima, Y. Abe, J. Nishimura, H. Nawata, T. Watanabe, and K. Muta
Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells
Blood,
July 15, 2001;
98(2):
313 - 321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Fagerlie, J. Diaz, T. A. Christianson, K. McCartan, W. Keeble, G. R. Faulkner, and G. C. Bagby
Functional correction of FA-C cells with FANCC suppresses the expression of interferon {gamma}-inducible genes
Blood,
May 15, 2001;
97(10):
3017 - 3024.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Moreau, M. Leite-de-Moraes, S. Ezine, J. P. Di Santo, M. Dy, and E. Schneider
Natural killer cell-dependent apoptosis of peripheral murine hematopoietic progenitor cells in response to Fas cross-linking: involvement of tumor necrosis factor-{alpha}
Blood,
May 15, 2001;
97(10):
3069 - 3074.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Liu, Y. Yu, M. Zhang, W. Wang, and X. Cao
The Involvement of TNF-{{alpha}}-Related Apoptosis-Inducing Ligand in the Enhanced Cytotoxicity of IFN-{{beta}}-Stimulated Human Dendritic Cells to Tumor Cells
J. Immunol.,
May 1, 2001;
166(9):
5407 - 5415.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Gisslinger, R. Kurzrock, B. Gisslinger, S. Jiang, S. Li, I. Virgolini, W. Woloszczuk, M. Andreeff, and M. Talpaz
Autocrine cell suicide in a Burkitt lymphoma cell line (Daudi) induced by interferon {alpha}: involvement of tumor necrosis factor as ligand for the CD95 receptor
Blood,
May 1, 2001;
97(9):
2791 - 2797.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Sloand, J. Maciejewski, P. Kumar, S. Kim, A. Chaudhuri, and N. Young
Protease inhibitors stimulate hematopoiesis and decrease apoptosis and ICE expression in CD34+ cells
Blood,
October 15, 2000;
96(8):
2735 - 2739.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Thornton, G. P. Boivin, K. N. Kim, F. D. Finkelman, and R. Hirsch
Heterogeneous Effects of IL-2 on Collagen-Induced Arthritis
J. Immunol.,
August 1, 2000;
165(3):
1557 - 1563.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Diamond and R. G. Gill
An Essential Contribution by IFN-{gamma} to CD8+ T Cell-Mediated Rejection of Pancreatic Islet Allografts
J. Immunol.,
July 1, 2000;
165(1):
247 - 255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Zamai, P. Secchiero, S. Pierpaoli, A. Bassini, S. Papa, E. S. Alnemri, L. Guidotti, M. Vitale, and G. Zauli
TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis
Blood,
June 15, 2000;
95(12):
3716 - 3724.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Choi, K. Muta, A. Wickrema, S. B. Krantz, J. Nishimura, and H. Nawata
Interferon gamma delays apoptosis of mature erythroid progenitor cells in the absence of erythropoietin
Blood,
June 15, 2000;
95(12):
3742 - 3749.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Liu, S. Wei, T. Lamy, P. K. Epling-Burnette, G. Starkebaum, J. Y. Djeu, and T. P. Loughran Jr
Chronic neutropenia mediated by Fas ligand
Blood,
May 15, 2000;
95(10):
3219 - 3222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. O'Donnell, Y. Luo, X. Chen, A. Szilvasi, S. E. Hunter, and S. K. Clinton
Role of IL-12 in the Induction and Potentiation of IFN-{gamma} in Response to Bacillus Calmette-Guerin
J. Immunol.,
October 15, 1999;
163(8):
4246 - 4252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Schneider, G. Moreau, A. Arnould, F. Vasseur, N. Khodabaccus, M. Dy, and S. Ezine
Increased Fetal and Extramedullary Hematopoiesis in Fas-Deficient C57BL/6-lpr/lpr Mice
Blood,
October 15, 1999;
94(8):
2613 - 2621.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Sol, J. Le Junter, I. Vassias, J. M. Freyssinier, A. Thomas, A. F. Prigent, B. B. Rudkin, S. Fichelson, and F. Morinet
Possible Interactions between the NS-1 Protein and Tumor Necrosis Factor Alpha Pathways in Erythroid Cell Apoptosis Induced by Human Parvovirus B19
J. Virol.,
October 1, 1999;
73(10):
8762 - 8770.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Ariza, M. Broome-Powell, J. M. Lahti, V. J. Kidd, and M. A. Nelson
Fas-induced Apoptosis in Human Malignant Melanoma Cell Lines Is Associated with the Activation of the p34cdc2-related PITSLRE Protein Kinases
J. Biol. Chem.,
October 1, 1999;
274(40):
28505 - 28513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Martins, L. Q. Vieira, F. Q. Cunha, and J. S. Silva
Gamma Interferon Modulates CD95 (Fas) and CD95 Ligand (Fas-L) Expression and Nitric Oxide-Induced Apoptosis during the Acute Phase of Trypanosoma cruzi Infection: a Possible Role in Immune Response Control
Infect. Immun.,
August 1, 1999;
67(8):
3864 - 3871.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Sedger, D. M. Shows, R. A. Blanton, J. J. Peschon, R. G. Goodwin, D. Cosman, and S. R. Wiley
IFN-{gamma} Mediates a Novel Antiviral Activity Through Dynamic Modulation of TRAIL and TRAIL Receptor Expression
J. Immunol.,
July 15, 1999;
163(2):
920 - 926.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Ishimaru, K. Saegusa, K. Yanagi, N. Haneji, I. Saito, and Y. Hayashi
Estrogen Deficiency Accelerates Autoimmune Exocrinopathy in Murine Sjogren's Syndrome through Fas-Mediated Apoptosis
Am. J. Pathol.,
July 1, 1999;
155(1):
173 - 181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. G. Wickremasinghe and A. V. Hoffbrand
Biochemical and Genetic Control of Apoptosis: Relevance to Normal Hematopoiesis and Hematological Malignancies
Blood,
June 1, 1999;
93(11):
3587 - 3600.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Dai and S. B. Krantz
Interferon {gamma} Induces Upregulation and Activation of Caspases 1, 3, and 8 to Produce Apoptosis in Human Erythroid Progenitor Cells
Blood,
May 15, 1999;
93(10):
3309 - 3316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Moulian, C. Renvoize, C. Desodt, A. Serraf, and S. Berrih-Aknin
Functional Fas Expression in Human Thymic Epithelial Cells
Blood,
April 15, 1999;
93(8):
2660 - 2670.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. De Maria, U. Testa, L. Luchetti, A. Zeuner, G. Stassi, E. Pelosi, R. Riccioni, N. Felli, P. Samoggia, and C. Peschle
Apoptotic Role of Fas/Fas Ligand System in the Regulation of Erythropoiesis
Blood,
February 1, 1999;
93(3):
796 - 803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Lamy, J. H. Liu, T. H. Landowski, W. S. Dalton, and T. P. Loughran Jr
Dysregulation of CD95/CD95 Ligand-Apoptotic Pathway in CD3+ Large Granular Lymphocyte Leukemia
Blood,
December 15, 1998;
92(12):
4771 - 4777.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Selleri, J. P. Maciejewski, F. Pane, L. Luciano, A. M. Raiola, I. Mostarda, F. Salvatore, and B. Rotoli
Fas-Mediated Modulation of Bcr/Abl in Chronic Myelogenous Leukemia Results in Differential Effects on Apoptosis
Blood,
August 1, 1998;
92(3):
981 - 989.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Mitsiades, V. Poulaki, V. Kotoula, G. Mastorakos, S. Tseleni-Balafouta, D. A. Koutras, and M. Tsokos
Fas/Fas Ligand Up-Regulation and BCL-2 Down-Regulation May Be Significant in the Pathogenesis of Hashimoto's Thyroiditis
J. Clin. Endocrinol. Metab.,
June 1, 1998;
83(6):
2199 - 2203.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. S. Haneline, H. E. Broxmeyer, S. Cooper, G. Hangoc, M. Carreau, M. Buchwald, and D. W. Clapp
Multiple Inhibitory Cytokines Induce Deregulated Progenitor Growth and Apoptosis in Hematopoietic Cells From Fac-/- Mice
Blood,
June 1, 1998;
91(11):
4092 - 4098.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Halaas, R. Vik, and T. Espevik
Induction of Fas Ligand in Murine Bone Marrow NK Cells by Bacterial Polysaccharides
J. Immunol.,
May 1, 1998;
160(9):
4330 - 4336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Hasegawa, S. Kojima, E. Tatsumi, A. Hayakawa, Y. Kosaka, H. Nakamura, M. Sako, Y. Osugi, S. Nagata, and K. Sano
Elevation of the Serum Fas Ligand in Patients With Hemophagocytic Syndrome and Diamond-Blackfan Anemia
Blood,
April 15, 1998;
91(8):
2793 - 2799.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Moses, J. Nelson, and G. C. Bagby Jr
The Influence of Human Immunodeficiency Virus-1 on Hematopoiesis
Blood,
March 1, 1998;
91(5):
1479 - 1495.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-H. Dai, J. O. Price, T. Brunner, and S. B. Krantz
Fas Ligand Is Present in Human Erythroid Colony-Forming Cells and Interacts With Fas Induced by Interferon gamma to Produce Erythroid Cell Apoptosis
Blood,
February 15, 1998;
91(4):
1235 - 1242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sato, C. Selleri, N. S. Young, and J. P. Maciejewski
Inhibition of Interferon Regulatory Factor-1 Expression Results in Predominance of Cell Growth Stimulatory Effects of Interferon-gamma Due to Phosphorylation of Stat1 and Stat3
Blood,
December 15, 1997;
90(12):
4749 - 4758.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Iijima, K. Miyamura, T. Itou, M. Tanimoto, R. Sobue, and H. Saito
Functional Expression of Fas (CD95) in Acute Myeloid Leukemia Cells in the Context of CD34 and CD38 Expression: Possible Correlation With Sensitivity to Chemotherapy
Blood,
December 15, 1997;
90(12):
4901 - 4909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Dybedal, F. Guan, O. J. Borge, O. P. Veiby, V. Ramsfjell, S. Nagata, and S. E. W. Jacobsen
Transforming Growth Factor-beta 1 Abrogates Fas-Induced Growth Suppression and Apoptosis of Murine Bone Marrow Progenitor Cells
Blood,
November 1, 1997;
90(9):
3395 - 3403.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Jennings and K. A. Foon
Recent Advances in Flow Cytometry: Application to the Diagnosis of Hematologic Malignancy
Blood,
October 15, 1997;
90(8):
2863 - 2892.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-J. Geng, L. E. Henderson, E. B. Levesque, M. Muszynski, and P. Libby
Fas Is Expressed in Human Atherosclerotic Intima and Promotes Apoptosis of Cytokine-Primed Human Vascular Smooth Muscle Cells
Arterioscler Thromb Vasc Biol,
October 1, 1997;
17(10):
2200 - 2208.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Horikawa, H. Nakakuma, T. Kawaguchi, N. Iwamoto, S. Nagakura, T. Kagimoto, and K. Takatsuki
Apoptosis Resistance of Blood Cells From Patients With Paroxysmal Nocturnal Hemoglobinuria, Aplastic Anemia, and Myelodysplastic Syndrome
Blood,
October 1, 1997;
90(7):
2716 - 2722.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yoshikawa, T. Sakihama, Y. Nakajima, and K. Tasaka
Fcgamma RIII-Mediated Regulation of Hematopoiesis in Murine Bone Marrow Cells by Interleukin-3 and CD95 (Fas/Apo-1)
Blood,
September 1, 1997;
90(5):
1911 - 1919.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Rathbun, G. R. Faulkner, M. H. Ostroski, T. A. Christianson, G. Hughes, G. Jones, R. Cahn, R. Maziarz, G. Royle, W. Keeble, et al.
Inactivation of the Fanconi Anemia Group C Gene Augments Interferon-gamma -Induced Apoptotic Responses in Hematopoietic Cells
Blood,
August 1, 1997;
90(3):
974 - 985.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Lee, C. Beckham, B. R. Michel, H. Rosen, and H. J. Deeg
HLA-DR-Mediated Signals for Hematopoiesis and Induction of Apoptosis Involve But Are Not Limited to a Nitric Oxide Pathway
Blood,
July 1, 1997;
90(1):
217 - 225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. S. Young and J. Maciejewski
The Pathophysiology of Acquired Aplastic Anemia
N. Engl. J. Med.,
May 8, 1997;
336(19):
1365 - 1372.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Baker, R. L. Riley, E. R. Podack, and R. B. Levy
Graft-versus-host-disease-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell-mediated Fas-ligand function, but not perforin function
PNAS,
February 18, 1997;
94(4):
1366 - 1371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Selleri, T. Sato, L. Del Vecchio, L. Luciano, A. J. Barrett, B. Rotoli, N. S. Young, and J. P. Maciejewski
Involvement of Fas-Mediated Apoptosis in the Inhibitory Effects of Interferon-alpha in Chronic Myelogenous Leukemia
Blood,
February 1, 1997;
89(3):
957 - 964.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|